Ester Falconer - 01 Sep 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Chief Technology Officer
Signature: /s/ Tryn Stimart, attorney-in-fact
Issuer symbol: ABCL
Transactions as of: 01 Sep 2021
Net transactions value: +$14,778,750
Form type: 4
Filing time: 03 Sep 2021, 16:18:57 UTC
Previous filing: 10 Jun 2021
Next filing: 24 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABCL	Common Shares	Options Exercise	$14,778,750	+875,000		$16.89	875,000	01 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABCL	Share option (right to buy)	Options Exercise	$0	-875,000	-50%	$0.000000	875,000	01 Sep 2021	Common Shares	875,000	$0.3100	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on January 1, 2020, subject to the Reporting Person's continuous service to the Issuer on each such date